Sort
23,748 grants matching “melanoma”
Mechanism and Inhibition of Collagenolytic Activity
$352,963Gregg B Fields · Torrey Pines Inst For Molecular Studies · R01 · FY2011 · CA
MOLECULAR EPIDEMIOLOGY OF NON-MELANOMA SKIN CANCER
$352,932Harvard University (Sch Of Public Hlth) · R01 · FY2000 · CA
Systemic RNA interference to reactivate p53 tumor suppression
$352,899Alexander H. Stegh · Northwestern University At Chicago · R01 · FY2021 · CA
Project 1 - Integrating targeted and immune therapies for BRAF mutant colorectal cancer
$352,875Arlene H Sharpe · Dana-Farber Cancer Inst · P50 · FY2019 · CA
AIDS, Immune Activation and Mental Health
$352,838Robert Dantzer · University Of Illinois At Urbana-Champaign · R01 · FY2010 · MH
AIDS, Immune Activation and Mental Health
$352,838Robert Dantzer · University Of Illinois At Urbana-Champaign · R01 · FY2008 · MH
AIDS, Immune Activation and Mental Health
$352,838Robert Dantzer · University Of Illinois At Urbana-Champaign · R01 · FY2007 · MH
AIDS, Immune Activation and Mental Health
$352,838Robert Dantzer · University Of Illinois At Urbana-Champaign · R01 · FY2009 · MH
SENIOR LEADERSHIP
$352,823William L. Carroll · New York University School Of Medicine · P30 · FY2016 · CA
Targeting Lymphatic Vessels for Ligand Directed Imaging
$352,801Renata Pasqualini · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA
Role of CPT1A as a lysine succinyltransferase in tumorigenesis
$352,801Taro Hitosugi · Mayo Clinic Rochester · R01 · FY2019 · CA
The role of dietary copper in melanoma
$352,801Christopher M Counter · Duke University · R01 · FY2019 · CA
Develop CTC capture technology for both mesenchymal and non-mesenchymal tumors
$352,800Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · EB
Mechanism of double-negative T cells in antitumor immunity to breast cancer
$352,757Hui Zhang · University Of Louisville · R01 · FY2025 · CA
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm
$352,750Huiyan Zeng · Beth Israel Deaconess Medical Center · R01 · FY2010 · CA
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm
$352,750Huiyan Zeng · Beth Israel Deaconess Medical Center · R01 · FY2009 · CA
Spectral Imaging of Melanoma Cell Adhesion &Metastasis
$352,690University Of Pittsburgh At Pittsburgh · R01 · FY2004 · CA
An Immune Based Therapeutic Approach for Prostate Cancer
$352,615Esteban Celis · Mayo Clinic Rochester · P50 · FY2009 · CA
An Immune Based Therapeutic Approach for Prostate Cancer
$352,615Esteban Celis · Mayo Clinic Rochester · P50 · FY2010 · CA
Research Project 1 - Targeting the MAPK and PI3K pathways in melanoma PDX
$352,598Meenhard Herlyn · Wistar Institute · U54 · FY2020 · CA
Selective inhibition of nitric oxide synthase for multiple indications
$352,516Richard B Silverman · Northwestern University · R35 · FY2019 · GM
Project 2: Contribution of the Stromal Microenvironment to Early Dissemination
$352,446Mayumi Ito · New York University School Of Medicine · U54 · FY2022 · CA
Study of Hepatic Arterial Infusion of Melphalan for Malignancy in the liver
$352,372Michelle Hughes · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man
$352,335Richard C Koya · Roswell Park Cancer Institute Corp · R01 · FY2015 · CA
TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man
$352,335Richard C Koya · Roswell Park Cancer Institute Corp · R01 · FY2017 · CA